World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
61
Citations
15635
World Ranking
3213
National Ranking
124

Geert van Amerongen publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Geert van Amerongen sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 160 publications — 20th percentile

20% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Geert van Amerongen D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Geert van Amerongen sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 61 D-Index — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Geert van Amerongen is affiliated with Erasmus University Rotterdam in the Netherlands. Their research career primarily focuses on the field of Medicine, with significant contributions to subfields such as Infectious Diseases, Epidemiology, Animal Science and Zoology, Molecular Biology, and Cardiology and Cardiovascular Medicine.

The main research topics covered by Geert van Amerongen include:

  • SARS-CoV-2 and COVID-19 Research
  • Respiratory viral infections research
  • COVID-19 Clinical Research Studies
  • Animal Virus Infections Studies
  • Influenza Virus Research Studies
  • Viral gastroenteritis research and epidemiology
  • Vaccines and immunoinformatics approaches

Their recent publications span prominent journals and cover viral pathogenesis, susceptibility, and clinical effects across various models. Notable papers include:

  • "Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model" (2020) in Science
  • "Susceptibility of rabbits to SARS-CoV-2" (2020) in Emerging Microbes & Infections
  • "SARS-CoV-2 Omicron variant causes mild pathology in the upper and lower respiratory tract of hamsters" (2022) in Nature Communications
  • "Comparative Pathogenesis Of COVID-19, MERS And SARS In A Non-Human Primate Model" (2020) in bioRxiv (Cold Spring Harbor Laboratory)
  • "Influenza-induced thrombocytopenia is dependent on the subtype and sialoglycan receptor and increases with virus pathogenicity" (2020) in Blood Advances

Frequent collaborators in their work include:

  • Bart L. Haagmans
  • Kate Guilfoyle
  • Mart M. Lamers
  • Judith M. A. van den Brand
  • Wolfgang Baumgärtner

Geert van Amerongen's research has been published repeatedly in several key venues, including:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Emerging Microbes & Infections
  • npj Vaccines
  • Frontiers in Immunology
  • SSRN Electronic Journal

The emphasis of their research on infectious diseases, particularly focusing on viral pathogens that affect respiratory systems and animal models, highlights their role in understanding viral dynamics and disease mechanisms relevant to public health. Their studies also intersect with immunological approaches to vaccine development and disease prevention strategies.

Best Publications

  • Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome

    Thijs Kuiken;Ron A.M. Fouchier;Martin Schutten;Guus F. Rimmelzwaan

  • Aetiology: Koch's postulates fulfilled for SARS virus.

    Ron A. M. Fouchier;Thijs Kuiken;Martin Schutten;Geert van Amerongen

  • Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model.

    Barry Rockx;Thijs Kuiken;Sander Herfst;Theo Bestebroer

  • Virology: SARS virus infection of cats and ferrets.

    Byron E. E. Martina;Bart L. Haagmans;Thijs Kuiken;Ron A. M. Fouchier

  • Avian H5N1 Influenza in Cats

    Thijs Kuiken;Guus Rimmelzwaan;Debby van Riel;Geert van Amerongen

  • Wild ducks as long-distance vectors of highly pathogenic avian influenza virus (H5N1).

    Juthatip Keawcharoen;Debby van Riel;Geert van Amerongen;Theo M. Bestebroer

  • Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques.

    Bart L. Haagmans;Thijs Kuiken;Byron Ee E Martina;Ron Am M Fouchier

  • Influenza A virus (H5N1) infection in cats causes systemic disease with potential novel routes of virus spread within and between hosts.

    Guus F. Rimmelzwaan;Debby van Riel;Marianne Baars;Theo M. Bestebroer

  • Exacerbated innate host response to SARS-CoV in aged non-human primates

    Saskia L. Smits;Anna de Lang;Judith M A van den Brand;Lonneke M Leijten

  • Predominant infection of CD150+ lymphocytes and dendritic cells during measles virus infection of macaques.

    Rik L de Swart;Martin Ludlow;Lot de Witte;Yusuke Yanagi

  • Early target cells of measles virus after aerosol infection of non-human primates

    Ken Lemon;Rory D de Vries;Annelies W Mesman;Stephen McQuaid

  • Modified Vaccinia Virus Ankara Protects Macaques against Respiratory Challenge with Monkeypox Virus

    Koert J. Stittelaar;Geert van Amerongen;Ivanela Kondova;Thijs Kuiken

  • Antiviral treatment is more effective than smallpox vaccination upon lethal monkeypox virus infection

    Koert J Stittelaar;Johan Neyts;Lieve Naesens;Geert van Amerongen

  • Safety of modified vaccinia virus Ankara (MVA) in immune-suppressed macaques

    Koert J. Stittelaar;Thijs Kuiken;Rik L. de Swart;Geert van Amerongen

  • Cross-protection against lethal H5N1 challenge in ferrets with an adjuvanted pandemic influenza vaccine.

    Benoît Baras;Koert J Stittelaar;James H S Simon;Robert J. M. M. Thoolen

  • Measles Immune Suppression: Lessons from the Macaque Model

    Rory D. de Vries;Stephen McQuaid;Geert van Amerongen;Selma Yüksel

  • Experimental Human Metapneumovirus Infection of Cynomolgus Macaques (Macaca fascicularis) Results in Virus Replication in Ciliated Epithelial Cells and Pneumocytes with Associated Lesions throughout the Respiratory Tract

    Thijs Kuiken;Bernadette G. van den Hoogen;Debby A.J. van Riel;Jon D. Laman

  • Adenosine Deaminase Acts as a Natural Antagonist for Dipeptidyl Peptidase 4-Mediated Entry of the Middle East Respiratory Syndrome Coronavirus

    V Stalin Raj;Saskia L Smits;Lisette B Provacia;Judith M A van den Brand

  • Viral replication and development of specific immunity in macaques after infection with different measles virus strains.

    Robert S. van Binnendijk;Roger W. J. van der Heijden;Geert van Amerongen;Fons G. C. M. UytdeHaag

  • Protective Immunity in Macaques Vaccinated with a Modified Vaccinia Virus Ankara-Based Measles Virus Vaccine in the Presence of Passively Acquired Antibodies

    Koert J. Stittelaar;Linda S. Wyatt;Rik L. de Swart;Helma W. Vos

Frequent Co-Authors

Albert D. M. E. Osterhaus
Albert D. M. E. Osterhaus University of Veterinary Medicine Hannover, Foundation
Thijs Kuiken
Thijs Kuiken Erasmus University Rotterdam
Rik L. de Swart
Rik L. de Swart Erasmus University Rotterdam
Ron A. M. Fouchier
Ron A. M. Fouchier Erasmus University Rotterdam
Guus F. Rimmelzwaan
Guus F. Rimmelzwaan University of Veterinary Medicine Hannover, Foundation
Bart L. Haagmans
Bart L. Haagmans Erasmus University Rotterdam
W. Paul Duprex
W. Paul Duprex University of Pittsburgh
Sander Herfst
Sander Herfst Erasmus University Rotterdam
Theo M. Bestebroer
Theo M. Bestebroer Erasmus University Rotterdam

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, exploring related healthcare fields can open diverse career pathways. Nursing degrees often complement the study of immunology, with several accessible options available online. For example, students seeking a quicker entry into nursing might consider the easiest accelerated nursing programs to get into, which combine rigor with streamlined admissions.

Licensed Practical Nursing (LPN) is another valuable credential, especially for those looking to gain hands-on patient care experience. Many accredited programs offer flexible formats, and researching accredited lpn programs easy to get into can help prospective students find suitable options that fit their needs.

Advancing further, becoming a nurse practitioner (NP) provides broader scope and autonomy in clinical practice. Prospective students should review the easiest np program listings to identify programs balancing accessibility and quality education.

For those particularly interested in mental health, best online psychiatric mental health nurse practitioner programs offer specialized training and strong clinical placement opportunities, paving the way for careers that integrate immunological insights with psychiatric care.

Best Scientists Citing Geert van Amerongen

Trending Scientists

Recently Published Articles